Your Location:
Home >
Browse articles >
ADP-dependent glucokinase controls metabolic fitness in prostate cancer progression
RESEARCH | Updated:2025-12-13
    • ADP-dependent glucokinase controls metabolic fitness in prostate cancer progression

    • In the field of prostate cancer treatment, researchers have identified ADP-dependent glucokinase (ADPGK) as a crucial target. The study found that high ADPGK expression is associated with poor survival outcomes in prostate cancer patients. ADPGK accelerates cancer glycolysis and progression by activating the ALDOC-AMPK signaling pathway, laying a foundation for the construction of a new treatment and prognosis evaluation system for prostate cancer.
    • Military Medical Research   Vol. 11, Issue 5, Pages: 643-662(2024)
    • DOI:10.1186/s40779-023-00500-9    

      CLC:
    • Published:2024-10

    Scan QR Code

  • Cite this article as: Xu H, Li YF, Yi XYL, Zheng XN, Yang Y, Wang Y, et al. ADP-dependent glucokinase controls metabolic fitness in prostate cancer progression. Mil Med Res. 2023;10(1):64. DOI: 10.1186/s40779-023-00500-9.

  •  
  •  

0

Views

0

Downloads

1

CSCD

Alert me when the article has been cited
Submit
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Emerging roles of ADP-dependent glucokinase in prostate cancer
ADP-dependent glucokinase: the ancient, archaeal key to prostate cancer
Intelligent medicine in focus: the 5 stages of evolution in robot-assisted surgery for prostate cancer in the past 20 years and future implications
Simulation Analysis on Static Performance of EP Solenoid Valves Based on ANSYS
Research on Reinforcement Technique to Enhance Lateral Stiffness of Steel Truss Bridge on Existing Railway

Related Author

Xu Zhang
Marcin M. Kamiński
Bai-Rong Shen
Qiang Wei
Lu Yang
Jia-Ming Zheng
Qi Deng
Qi-Yu Zhu

Related Institution

Department of Urology, the Third Medical Centre, Chinese PLA General Hospital
Department of Immunology, St. Jude Children’s Research Hospital
Institutes for Systems Genetics, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University
Department of Computer Science and Information Technologies, Elviña Campus, University of A Coruña
Chinese Academy of Medical Science Oxford Institute, Nuffield Department of Medicine, University of Oxford
0